Nasdaq

Intelligent Bio Solutions Inc. Announces New Data Supporting Drug Screening System Ahead of FDA 510(k) Submission

Intelligent Bio Solutions Inc. (INBS) announced the successful collection of new data that reinforces the performance of its Intelligent Fingerprinting Drug Screening System, which is crucial for its ...
Nasdaq

Intelligent Bio Solutions Inc. Submits FDA 510(k) Application for Intelligent Fingerprinting Drug Screening System

Intelligent Bio Solutions Inc. (INBS) has submitted a 510(k) premarket notification to the FDA for its Intelligent Fingerprinting Drug Screening System, a rapid and non-invasive drug testing method ...
Benzinga.com

What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday?

Monday, Intelligent Bio Solutions Inc. (NASDAQ:INBS) stock is trading higher with a session volume of 62.49 million compared to the average volume of 154k, as per data from Benzinga Pro. The company ...
Morningstar

From Reshaping Newborn Screening to Redefining Longevity Science, Bio-IT World 2025 Will Highlight Transformative Applications of New Technologies

Distinguished Biotech, Pharmaceutical and Healthcare Leaders Will Headline Three Days of Inspiring Innovation at the 24th Annual Conference & Expo, April 2-4 in Boston BOSTON, March 13, 2025 ...
Morningstar

EvE Bio and DrugBank Partner to Bring Record-Scale Pharmome-Mapping Data to the Drug-Discovery Community

Commercial sponsorship integrates EvE Bio's growing field‑defining "pharmome" map - 385,572 rigorously confirmed drug–target interactions across 159 validated targets - into DrugBank's intelligence ...